Global Stem Cells Group announces plans to sign a strategic alliance with BioTrend Turkey, an innovative biotechnology company focused on genetic, biochemistry, molecular biology, biomaterials and stem cell technologies.
MIAMI, Nov. 20, 2017— Global Stem Cells Group (GSCG), a world leader in stem cell and regenerative medicine, announced plans to sign a strategic alliance with international biotechnology company BioTrend, which services the Turkish health sector.
GSCG’s goals for the alliance are three-fold:

• Organize Turkey’s first International Society for Stem Cell Application (ISSCA) regenerative medicine symposium in April 2018, in Istanbul.
• Host two hands-on regenerative medicine certification training courses per year in Turkey.
• BioTrend will promote and distribute Adimarket regenerative medicine equipment and supplies in the region.

The two-day, hands-on training courses were developed for physicians and high-level practitioners to learn techniques in harvesting and reintegrating stem cells derived from adipose tissue and bone marrow. Coursework will focus on stem cell technologies and regenerative medicine protocols. Participating physicians learn skills that can be used to treat patients in their practices, and for career advancement.
“This new alliance with BioTrend is a great opportunity to advance the benefits of stem cell medicine in Turkey,” says Global Stem Cells Group CEO Benito Novas.  “Turkey’s geographic location bridges Europe and Asia, allowing GSCG to have a widespread influence in establishing our regenerative medicine presence in both Europe and Asia.
“We are excited to work with BioTrend’s innovative team, and move one step closer to establishing Global Stem Cells Group as the leader in regenerative medicine therapies worldwide.”
The alliance is part of Global Stem Cells Group’s push to highlight Turkey’s appeal as a destination for patients seeking stem cell therapies for a variety of conditions.
Stem cell therapies continue to revolutionize the anti-aging aesthetics industry and help improve the quality of life for patients suffering from some chronic conditions.
To learn more about the Global Stem Cells Group Symposium in Istanbul, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call 305-560-5337.
About Global Stem Cells Group:
Global Stem Cells Group (GSCG) Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
Global stem cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world.
About AdiMarket:


Adimarket, Inc., a division of the Global Stem Cells Group, is a one-stop, cost-competitive online marketplace for quality regenerative medicine equipment and supplies for physicians and health care professionals.
Adimarket was founded to provide practitioners the tools they need to practice regenerative medicine in a medical office setting. Motivated by a firm belief in the impact stem cell medicine can have when dispensed in a doctor’s office, Adimarket provides physicians with the tools they need to provide patients with cutting-edge treatments.
About BioTrend:
BioTrend was established in Cleveland, Ohio, in 2004, and has been serving the Turkish health sector since 2005. As part of the textile and construction company group, BioTrend benefits from the group`s 25 years of international business experience to move forward stronger and more professionally.
BioTrend focuses on genetic, biochemistry, molecular biology, biomaterials and stem cell technologies; the company has introduced a significant number of innovative technologies to the Turkish healthcare industry. The technologies and products which are safe, high technology and proved their quality in the world are marketed and distributed by BioTrend in Turkey.

The International Society for Stem Cell Application (ISSCA) will host a specialized training conference in pain management and cosmetic gynecology in Madrid, Feb. 24-25, 2018. Featured speakers include three prominent experts in these specialized fields.

MIAMI, Nov. 13, 2017— The International Society for Stem Cell Application (ISSCA), a global leader in regenerative medicine education, research, and certification, will host a specialized training workshop in pain management and cosmetic gynecology for physicians and qualified health care practitioners at the Advanced Pain Management Center in Madrid, Feb. 24-25, 2018. The event will feature three distinguished speakers with diverse experience in these specialized fields.
Training at the event will focus on regenerative medicine solutions for pain management and cosmetic gynecology. Learning new techniques in pain management requires a thorough understanding of how to perform and administer the latest therapies that are simple for physicians to learn and execute in-office, but many haven’t learned them yet.
The field of cosmetic gynecology is associated with three specialties: gynecology, cosmetic surgery, and dermatology. It comprises a wide range of procedures, from vaginal rejuvenation to vaginoplasty and labiaplasty, and can involve surgery or non-invasive procedures that can be performed in-office without a need for anesthesia.
Speakers for the ISSCA Specialized Training Workshop in Pain Management and Cosmetic Gynecology, all experts in their fields, include:
Maritza Novas earned a medical degree at the University of Havana, Cuba in 1993. Novas, Director of Research and Development for Global Stem Cells Group, has been in the forefront of medical aesthetic and anti-aging medicine since 2001.
She has been a member of the American Academy of Anti-Aging Medicine since 2004 and draws upon 10 years of combined experience with facial aesthetics, hormonal replacement and nutritional therapies, liposculpture, and fat transfers. Novas is currently completing a master’s degree in Molecular Biology at Lehigh University.
A pioneer in the use of stem cells for aesthetic procedures and treatment of chronic degenerative conditions, she has trained more than 150 physicians in the U.S. and internationally on procedures and protocols for harvesting and isolating adipose-derived stem cells for autologous re-implantation, and with problem-solving methods to improve patient outcomes.
Novas specializes in stem cell procedures for cosmetic and anti-aging applications, tissue regeneration, functional medicine, age management, bio-identical hormone therapy, and weight control. Novas has been a certified Adistem specialist for more than four years.
As a member of Stem Cell Training, Inc.’s research and development team, Novas has assisted in the development of new proprietary adipose and bone marrow protocols currently being used in the company’s comprehensive stem cell training courses.
Ernesto Delgado Cidranes M.D., Ph.D., an expert in pain treatment and management, is a neuroanesthesiologist, and resuscitation and intensive care specialist in, Madrid, Spain. Cildranes provides an integrative and interdisciplinary approach to the treatment of pain and is a frequent speaker on the subject. His areas of expertise include interventional pain management, pain treatment, stem cell therapies, and regenerative medicine.
Cidranes is director, CEO, and founder at Advanced Pain and Aesthetic Management Center in Madrid. He serves as an editorial board member of the Journal Pain Management and Therapy; an editorial board member for the American Institute of Ultrasound in Medicine (AIUM); a reviewer and advisor for the Journal of Ultrasound in Medicine, American Institute, U.S.; a member of the World Pain Medicine Conferences organizing committee; chairman of the Department of Anesthesia and Pain Medicine, Spanish University Health Ministry. an international professor of advanced ultrasound in the Pain Unit at La Milagrosa and Los Madroños Hospitals in Madrid, and a staff member at Anesthesiology of Ruber Quirón Hospital in Madrid. He also serves on the Global Stem Cells Group Advisory Board.
Cidranes’ lecture for the event is titled “Stem Cells: Relieving pain, restoring function and generating hope.”
“The conscious, explicit, and judicious use of the best scientific evidence available to make
patient decisions is the key,” he says. “It is obvious that regenerative therapies have to carry the weight of medicine is based on scientific data I intend to show our experience on the use of stem cells in pain treatment to relieve pain, restore function and generate hope in our patients.”
According to Cidranes, research on the infusion of mesenchymal stem cells has clinical and technological monitoring in real time to guarantee the quality and safety of its extraction until its application. The treatment of pain is a human right and the application of stem cells is a tool, it´s a valid safety and demonstrates the option to improve the quality of life.
Zuramis ESTRADA BLANCO, M.D., is a cosmetic gynecologist and CEO, founder, and director of Advanced Aesthetic Surgery Center CIMEG Advanced Pain Management Center in Madrid.
Estrada specializes in obstetrics and aesthetic gynecology, senology and breast diseases, and pelvic floor disorders. She is a founding member of la Sociedad Española de Ginecoestética y Cirugía Intima (SEGECI), Spain’s first cosmetic gynecology society.
Zuramis teaches basic and advanced ultrasound in SERMAS to fourth- and fifth-year medical students at the Francisco de Vitoria University in Madrid, and serves as assistant specialist at Southeast University Hospital, also in Madrid.
She has dedicated more than 15 years to research and to the treatment of gynecological dysfunctions of women. She is president of the International Society of Aesthetic Gynecology and Research(ISGAR); a member of the expert committee of the International Association of Aesthetic Gynecology and Sexual Wellbeing (IAAGSW); general secretary of the Spanish Society of Gynecology Aesthetic Regenerative Functional (SEGERF); Creator of several working protocols for the treatment of pelvic floor and sexual dysfunctions, and a national and international guest speaker for courses and congresses in her field of medicine.
Click here to view a video of Zuramis’s recent lecture titled, “Vulvovaginal: pudendal pain relief with PRP and stem cells.”
To learn more about the ISSCA Specialized Training Workshop in Pain Management and Cosmetic Gynecology, visit http://stemcellsacademy.com, email info@stemcellsgroup.com, or call +1305 560 5337.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally.  Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
###
pain management workshop